drugset / Trial / NCT03386149

Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine

NCT03386149

RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled clinical trial is designed to evaluate the efficacy and safety of Bosinji on low back pain and radiating pain of lumbar herniated intervertebral disc (L-HIVD) by assessing pain, function, and quality of life.

Timeline

Start
2017-12-28
Primary completion
2019-12-27
Completion
2020-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosinji Traditional medicine (herbal / TCM) 2.5 g Oral
Comparator Loxoprofen Small molecule 60 mg Oral

Indications